Finance

Lists
4565:TYO
Nxera Pharma Co Ltd
1 264,00 JP¥
+1,20%
(+15,00) 1D
1-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4565...
Open
1 248 JP¥
High
1 265 JP¥
Low
1 221 JP¥
Mkt. cap
117,06 млд
Avg. vol.
1,24 млн
Volume
580,30 миң
52-wk high
1 319 JP¥
52-wk low
723 JP¥
EPS
-86 JP¥
Shares outstanding
76,30 млн
No. of employees
322
Open
1 248 JP¥
High
1 265 JP¥
Low
1 221 JP¥
Mkt. cap
117,06 млд
Avg. vol.
1,24 млн
Volume
580,30 миң
52-wk high
1 319 JP¥
52-wk low
723 JP¥
EPS
-86 JP¥
Shares outstanding
76,30 млн
No. of employees
322
News stories
From web sources and news partners
About Nxera Pharma Co Ltd
CEO-
Employees322
Founded1990-ж., 22-июн.
Headquarters-
SectorPharmaceutical industry
Websitenxera.life
Last report
2026-ж., 7-авг.
Fiscal period
Q2 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
7,65 млд / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
6,75 млд
7,77 млд
11,26 млд
7,65 млд
Cost of goods sold
2,67 млд
2,05 млд
1,12 млд
2,16 млд
Cost of revenue
2,67 млд
2,05 млд
1,12 млд
2,16 млд
Research and development expenses
3,73 млд
3,27 млд
3,03 млд
2,97 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,84 млд
363,00 млн
3,57 млд
3,38 млд
Operating expense
7,23 млд
8,08 млд
6,89 млд
6,85 млд
Total operating expenses
9,90 млд
10,13 млд
8,01 млд
9,02 млд
Operating income
-3,15 млд
-2,36 млд
3,24 млд
-1,36 млд
Other non operating income
-
-5,02 млд
-2,00 млн
2,00 млн
EBT including unusual items
-3,12 млд
-8,11 млд
3,04 млд
-1,64 млд
EBT excluding unusual items
-3,12 млд
-6,30 млд
3,04 млд
-1,64 млд
Income tax expense
-1,44 млд
-391,00 млн
1,25 млд
-1,44 млд
Effective tax rate
46,34%
4,82%
41,08%
87,71%
Other operating expenses
-338,00 млн
996,00 млн
295,00 млн
499,00 млн
Net income
-1,67 млд
-7,72 млд
1,79 млд
-202,00 млн
Net profit margin
-24,76%
-99,41%
15,93%
-2,64%
Earnings per share
-
-
-
-
Interest and investment income
239,00 млн
1,06 млд
144,00 млн
-
Interest expense
-204,00 млн
-
-287,00 млн
-488,00 млн
Net interest expenses
35,00 млн
1,06 млд
-143,00 млн
-488,00 млн
Depreciation and amortization charges
-
3,45 млд
-
-
EBITDA
-2,04 млд
-1,28 млд
4,35 млд
-268,00 млн
Gain or loss from assets sale
-
1,16 млд
-
1,21 млд
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору